Hara 2007.
Methods | Type of study: RCT. | |
Participants | Number of participants randomised: 52 Losses: 8 of 52 (6 exercise and 2 control) Age: Exercise 84.4 (5.6) Control 85.6 (4.8). Sex: women (n = 35) and men (n = 10). Setting: Japan, Health of participants: frail Residential Status: residential care facilities or frail visitors. Inclusion: walk independently or with an aid Exclusion: no specific criteria. |
|
Interventions | EXERCISE GROUP (MULTIPLE): Sit to stands, standing up to parallel bars, light weights for seated arm strengthening ‐ low balance challenge CONTROL GROUP: usual activity. Duration and intensity: 2 or 3 times a week for 6 months.‐ duration of exercise not reported, estimated at 30 mins a session Supervisor: not known. Supervision: not clear if in a group or on a one to one basis. Setting: gym in care home. | |
Outcomes | Functional Reach (cm) Timed Up and Go (clockwise and anticlockwise) (s) Walking time (s) Compliance/adherence: not reported. Adverse events: not reported |
|
Notes | Subjects in both groups also attended other group activities in the home. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | No randomisation method reported |
Allocation concealment (selection bias) | Unclear risk | Insufficient information to permit judgement |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Differences between drop outs and completers not reported |
Selective reporting (reporting bias) | Low risk | All outcome measures addressed |
Other bias | High risk | Both groups attended other group activities which may have influenced results as no account of how many or what |
Blinding (participant) | High risk | Not possible |
Blinding (assessor) | Unclear risk | Not reported |
Were the treatment and control group comparable at entry? | High risk | Only reported on age, weight and height (no differences) but although measured did not report on balance and strength |
Was the surveillance active, and of clinically appropriate duration (i.e. at least 3 months post intervention)? | High risk | Only immediately post intervention data, no follow‐up data reported. |